Please provide your email address to receive an email when new articles are posted on . Artificial neural networks model better predicted 28-day mortality in hepatic encephalopathy vs. MELD, MELD-Na ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score ...
Liver transplant candidates may get a fairer shake from an artificial intelligence-based organ allocation system than that offered by the current Model for End-Stage Liver Disease (MELD) scoring ...
Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
Bilirubin interference in the widely used Jaffe creatinine assay led to artificially elevated Model for End-Stage Liver Disease (MELD) scores in a substantial proportion of patients with end-stage ...
Researchers have unveiled an advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score). This innovative tool, developed ...
Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...
End-stage liver disease patients at lower risk for death in the short term still reaped the substantial benefits of a living-donor liver transplant (LDLT), a case-control study revealed. Compared with ...
The Model for End-stage Liver Disease (MELD) score—derived from serum total bilirubin and creatinine levels, plus the international normalized ratio—is commonly used in the US to assess patients' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results